SpringWorks Therapeutics Stock Options
| SWTX Stock | USD 43.38 0.62 1.41% |
SpringWorks Therapeutics' option chain provides insight into all available option contracts written on SpringWorks Therapeutics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of SpringWorks Therapeutics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given SpringWorks option contract.
In The Money vs. Out of Money Option Contracts on SpringWorks Therapeutics
Analyzing SpringWorks Therapeutics' in-the-money options over time can help investors to take a profitable long position in SpringWorks Therapeutics regardless of its overall volatility. This is especially true when SpringWorks Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money SpringWorks Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with SpringWorks Therapeutics' stock while costing only a fraction of its price.
SpringWorks Therapeutics' latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 86.33 with a put-to-call open interest ratio of 0.61 over 22 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 5, with calls trading at the volume of 1. This yields a 5.0 put-to-call volume ratio. The SpringWorks Therapeutics option chain provides detailed quote and price information for the current SpringWorks Therapeutics option contracts. It shows all of SpringWorks Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
SpringWorks Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in SpringWorks Therapeutics' lending market. For example, when SpringWorks Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on SpringWorks Therapeutics, he or she must hedge the risk by shorting SpringWorks Therapeutics stock over its option's life.
2024-05-17
The chart above shows SpringWorks Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. SpringWorks Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for SpringWorks Therapeutics' option, there is no secondary market available for investors to trade.
SpringWorks Therapeutics Maximum Pain Price across 2024-05-17 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as SpringWorks Therapeutics close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
SpringWorks Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of SpringWorks Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell SpringWorks stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If SpringWorks Therapeutics' stock price goes up or down, the stock options follow.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SpringWorks Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. Please note that buying 'in-the-money' options on SpringWorks Therapeutics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if SpringWorks Therapeutics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money SpringWorks Therapeutics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if SpringWorks Stock moves the wrong way.
At this time, SpringWorks Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock is likely to rise to about 13.2 K in 2024, whereas Treasury Stock is likely to drop (792.9 K) in 2024. SpringWorks Therapeutics In The Money Call Balance
When SpringWorks Therapeutics' strike price is surpassing the current stock price, the option contract against SpringWorks Therapeutics stock is said to be in the money. When it comes to buying SpringWorks Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on SpringWorks Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
SpringWorks Current Options Market Mood
SpringWorks Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps SpringWorks Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of SpringWorks Therapeutics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. SpringWorks Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current SpringWorks Therapeutics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current SpringWorks contract
Base on the Rule 16, the options market is currently suggesting that SpringWorks Therapeutics will have an average daily up or down price movement of about 5.4% per day over the life of the 2024-05-17 option contract. With SpringWorks Therapeutics trading at USD 43.38, that is roughly USD 2.34. If you think that the market is fully incorporating SpringWorks Therapeutics' daily price movement you should consider buying SpringWorks Therapeutics options at the current volatility level of 86.33%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
SpringWorks |
Purchasing SpringWorks Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" SpringWorks calls. Remember, the seller must deliver SpringWorks Therapeutics stock to the call owner when a call is exercised.
SpringWorks Therapeutics Option Chain
When SpringWorks Therapeutics' strike price is surpassing the current stock price, the option contract against SpringWorks Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
SpringWorks Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on SpringWorks. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for SpringWorks. It also shows strike prices and maturity days for a SpringWorks Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $22.5 | 0.9506 | 0.0049 | 0 | 2024-05-17 | 20.2 - 24.0 | 0.0 | In |
Call | 2024-05-17 CALL at $25.0 | 0.9346 | 0.0066 | 0 | 2024-05-17 | 18.0 - 21.5 | 0.0 | In |
Call | 2024-05-17 CALL at $30.0 | 0.9133 | 0.0112 | 0 | 2024-05-17 | 13.0 - 16.5 | 0.0 | In |
Call | 2024-05-17 CALL at $35.0 | 0.8345 | 0.0203 | 0 | 2024-05-17 | 8.7 - 12.0 | 0.0 | In |
Call | 2024-05-17 CALL at $40.0 | 0.752 | 0.0436 | 109 | 2024-05-17 | 4.1 - 6.5 | 4.2 | In |
Call | 2024-05-17 CALL at $45.0 | 0.4988 | 0.0471 | 101 | 2024-05-17 | 0.65 - 3.4 | 3.0 | Out |
Call | 2024-05-17 CALL at $50.0 | 0.2615 | 0.043 | 49 | 2024-05-17 | 0.3 - 1.9 | 1.25 | Out |
Put | 2024-05-17 PUT at $70.0 | -0.9169 | 0.0116 | 0 | 2024-05-17 | 24.7 - 28.0 | 0.0 | In |
Put | 2024-05-17 PUT at $65.0 | -0.9087 | 0.0142 | 0 | 2024-05-17 | 19.7 - 23.0 | 0.0 | In |
Put | 2024-05-17 PUT at $60.0 | -0.8496 | 0.0202 | 0 | 2024-05-17 | 14.9 - 18.5 | 0.0 | In |
Put | 2024-05-17 PUT at $55.0 | -0.7963 | 0.0276 | 0 | 2024-05-17 | 10.6 - 13.3 | 0.0 | In |
Put | 2024-05-17 PUT at $50.0 | -0.7283 | 0.042 | 0 | 2024-05-17 | 6.2 - 8.0 | 0.0 | In |
Put | 2024-05-17 PUT at $45.0 | -0.5137 | 0.0538 | 5 | 2024-05-17 | 3.0 - 3.9 | 5.2 | In |
Put | 2024-05-17 PUT at $40.0 | -0.2739 | 0.0389 | 545 | 2024-05-17 | 1.05 - 2.15 | 1.0 | Out |
Put | 2024-05-17 PUT at $35.0 | -0.1919 | 0.0189 | 0 | 2024-05-17 | 0.2 - 2.5 | 1.8 | Out |
SpringWorks Therapeutics Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
SpringWorks Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in SpringWorks Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
SpringWorks Therapeutics Corporate Management
Elected by the shareholders, the SpringWorks Therapeutics' board of directors comprises two types of representatives: SpringWorks Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SpringWorks. The board's role is to monitor SpringWorks Therapeutics' management team and ensure that shareholders' interests are well served. SpringWorks Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SpringWorks Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Badreddin Edris | Chief Officer | Profile | |
| Mary Smith | Chief Officer | Profile | |
| Kim Diamond | Vice Relations | Profile | |
| James MD | Chief Officer | Profile | |
| Michael Nofi | Chief Officer | Profile | |
| TaiAn Lin | Chief Officer | Profile | |
| Saqib JD | CEO Director | Profile |
Already Invested in SpringWorks Therapeutics?
The danger of trading SpringWorks Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of SpringWorks Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than SpringWorks Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile SpringWorks Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether SpringWorks Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SpringWorks Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Springworks Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Springworks Therapeutics Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SpringWorks Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for SpringWorks Stock analysis
When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is SpringWorks Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SpringWorks Therapeutics. If investors know SpringWorks will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SpringWorks Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.15) | Revenue Per Share 0.086 | Return On Assets (0.32) | Return On Equity (0.55) |
The market value of SpringWorks Therapeutics is measured differently than its book value, which is the value of SpringWorks that is recorded on the company's balance sheet. Investors also form their own opinion of SpringWorks Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is SpringWorks Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SpringWorks Therapeutics' market value can be influenced by many factors that don't directly affect SpringWorks Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SpringWorks Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if SpringWorks Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SpringWorks Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.